- Report
- January 2022
- 419 Pages
Global
From €9184EUR$9,500USD£7,894GBP
- Report
- July 2018
- 17 Pages
Global
From €9667EUR$10,000USD£8,309GBP
- Report
- April 2023
- 109 Pages
Global
€3384EUR$3,500USD£2,908GBP
- Report
- January 2021
- 145 Pages
China, Global
From €3000EUR$3,324USD£2,669GBP
Beclomethasone is a corticosteroid drug used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is used to reduce inflammation in the airways, allowing for easier breathing. Beclomethasone is available in both inhaler and nebulizer forms, and is often prescribed in combination with other drugs. It is generally considered to be a safe and effective treatment for respiratory diseases.
Beclomethasone is a widely used drug in the respiratory market, and is available from many pharmaceutical companies. Some of the major players in the market include GlaxoSmithKline, Merck, Sanofi, and Teva Pharmaceuticals. Other companies such as Mylan, Sun Pharmaceuticals, and Zydus Cadila also produce beclomethasone products. Show Less Read more